Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Account Payables: 2015-2024

Historic Change in Account Payables for Abeona Therapeutics (ABEO) over the last 7 years, with Dec 2024 value amounting to -$5.0 million.

  • Abeona Therapeutics' Change in Account Payables fell 120.86% to -$296,000 in Q1 2022 from the same period last year, while for Mar 2022 it was -$18.1 million, marking a year-over-year decrease of 425.62%. This contributed to the annual value of -$5.0 million for FY2024, which is N/A change from last year.
  • Per Abeona Therapeutics' latest filing, its Change in Account Payables stood at -$5.0 million for FY2024, which was down 0.00% from -$5.0 million recorded in FY2022.
  • Over the past 5 years, Abeona Therapeutics' Change in Account Payables peaked at -$5.0 million during FY2022, and registered a low of -$16.4 million during FY2021.
  • For the 2-year period, Abeona Therapeutics' Change in Account Payables averaged around -$5.0 million, with its median value being -$5.0 million (2024).
  • Data for Abeona Therapeutics' Change in Account Payables shows a peak YoY soared of 69.53% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Abeona Therapeutics' Change in Account Payables stood at -$16.4 million in 2021, then surged by 69.53% to -$5.0 million in 2022, then reached -$5.0 million in 2024.